ÇANGA, A. Et Al. 2013. hrombin Activatable Fibrinolysis Inhibitor (TAFI) Activity In Patients with Isolated Coronary Artery Ectasia. International Journal of Clinical Research , vol.1, no.1 , 5-9.

ÇANGA, A., KOCAMAN, S. A., ÇETİN, M., KIRBAŞ, A., DURAKOĞLUGİL, M. E., ERDOĞAN, T., ... TEMİZ, A.(2013). hrombin Activatable Fibrinolysis Inhibitor (TAFI) Activity In Patients with Isolated Coronary Artery Ectasia. International Journal of Clinical Research , vol.1, no.1, 5-9.

ÇANGA, AYTUN Et Al. "hrombin Activatable Fibrinolysis Inhibitor (TAFI) Activity In Patients with Isolated Coronary Artery Ectasia," International Journal of Clinical Research , vol.1, no.1, 5-9, 2013

ÇANGA, AYTUN Et Al. "hrombin Activatable Fibrinolysis Inhibitor (TAFI) Activity In Patients with Isolated Coronary Artery Ectasia." International Journal of Clinical Research , vol.1, no.1, pp.5-9, 2013

ÇANGA, A. Et Al. (2013) . "hrombin Activatable Fibrinolysis Inhibitor (TAFI) Activity In Patients with Isolated Coronary Artery Ectasia." International Journal of Clinical Research , vol.1, no.1, pp.5-9.

@article{article, author={AYTUN ÇANGA Et Al. }, title={hrombin Activatable Fibrinolysis Inhibitor (TAFI) Activity In Patients with Isolated Coronary Artery Ectasia}, journal={International Journal of Clinical Research}, year=2013, pages={5-9} }